Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain.

Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain.

Item
http://www.wikidata.org/entity/Q38244523
Noninterventional study of transdermal fentanyl (fentavera) matrix patches in chronic pain patients: analgesic and quality of life effectsInnate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl.Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches.Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review.Cancer pain management: recommendations from a Latin-American experts panel.Evaluation of the Percutaneous Absorption of Ketamine HCl, Gabapentin, Clonidine HCl, and Baclofen, in Compounded Transdermal Pain Formulations, Using the Franz Finite Dose Model.Palliative care in ovarian carcinoma patients-a personalized approach of a team work: a review.Differences between Transdermal Fentanyl and Buprenorphine in the Elderly Hospice Patients
P2860

Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain.

Item
http://www.wikidata.org/entity/Q38244523
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Dosing considerations with tra ...... the treatment of cancer pain.
@en
type
label
Dosing considerations with tra ...... the treatment of cancer pain.
@en
prefLabel
Dosing considerations with tra ...... the treatment of cancer pain.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Dosing considerations with tra ...... the treatment of cancer pain.
@en
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P921
P932